Addex Therapeutics Reports First Half 2014 Financial Results - Seite 3

Tim Dyer, Chief Executive Officer
Addex Therapeutics
Telephone: [phone]
[e-mail]

Disclaimer / Forward-looking statements
This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Addex Therapeutics Ltd. This publication may contain certain forward-looking statements concerning the Company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the Company to be materially different from those expressed or implied by such statements. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update these forward-looking statements.

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Addex Therapeutics via Globenewswire

HUG#1859493

--- End of Message ---

Addex Therapeutics
12, chemin des Aulx Plan-les-Ouates; Geneva Switzerland

ISIN: CH0029850754;